Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Confounding in ex vivo models of Diamond-Blackfan anemia

Jacob C. Ulirsch, Caleb Lareau, Leif S. Ludwig, Narla Mohandas, David G. Nathan, Vijay G. Sankaran

Blood (2017) 130 (9): 1165–1168.

https://doi.org/10.1182/blood-2017-05-783191

Published: 2017

Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD

Blood (2015) 126 (23): 2178.

https://doi.org/10.1182/blood.V126.23.2178.2178

Published: 2015

Journal Articles

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

Jonathan R. Lindner, MD, Michael Widlansky, MD, Melinda D. Wu, MD, Jillian Dargatz, RN, Leanne M. Harmann, RDCS, RDMS, RVT, Todd Belcik, BS, RCS, RDCS, Donna S. Neuberg, ScD, David G. Nathan, MD, Joel Linden, PhD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2705.

https://doi.org/10.1182/blood.V124.21.2705.2705

Published: 2014

Journal Articles

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Elaine M. Majerus, MD PhD, Kenneth I. Ataga, MD, Elliott Vichinsky, MD, Cheryl A. Eaton, BA, Rosemary Mazanet, MD PhD, David G. Nathan, MD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2718.

https://doi.org/10.1182/blood.V124.21.2718.2718

Published: 2014

Journal Articles

Human Sickle Cell Disease Increases Numbers and Activation Of Peripheral Blood Myeloid Dendritic Cells, Monocytes, and Neutrophils

Gene Lin, MD, PhD, Jennifer C. Yu, MD, Joshua J. Field, MD, MS, David G. Nathan, MD, Joel Linden, PhD

Blood (2013) 122 (21): 1033.

https://doi.org/10.1182/blood.V122.21.1033.1033

Published: 2013

Journal Articles

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Joel Linden, PhD, Gene Lin, MD, PhD, Jennifer C. Yu, MD, Donna S. Neuberg, ScD, David G. Nathan, MD, Joshua J. Field, MD, MS

Blood (2013) 122 (21): 975.

https://doi.org/10.1182/blood.V122.21.975.975

Published: 2013

Journal Articles

A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients

Joshua J. Field, MD, MS, Kenneth I. Ataga, MD, Elaine Majerus, MD, PhD, Cheryl A. Eaton, BA, Robert Mashal, MD, David G. Nathan, MD

Blood (2013) 122 (21): 977.

https://doi.org/10.1182/blood.V122.21.977.977

Published: 2013

Journal Articles

Hemoglobin disorders: a look to the future

David G. Nathan

Blood (2013) 122 (6): 859–860.

https://doi.org/10.1182/blood-2013-06-506154

Published: 2013

Journal Articles

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan

Blood (2013) 121 (17): 3329–3334.

https://doi.org/10.1182/blood-2012-11-465963

Published: 2013

Includes: Supplemental data

Journal Articles

Cynomolgus Monkey Invariant NKT (iNKT) Cells Recover Following Depletion by Treatment with the Anti-Invariant T Cell Receptor Antibody NKTT120

Felix Scheuplein, Ph.D., Susan Macdonald, Ph.D., Brandon Zeigler, Ph.D., Elen LeBel, M.Sc., Abraham Thariath, Ph.D., Alem Truneh, Robert Mashal, M.D., David G. Nathan, MD, Robert Schaub, Ph.D.

Blood (2012) 120 (21): 4836.

https://doi.org/10.1182/blood.V120.21.4836.4836

Published: 2012

Journal Articles

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia

Khaled M. Musallam, Vijay G. Sankaran, Maria Domenica Cappellini, Lorena Duca, David G. Nathan, Ali T. Taher

Blood (2012) 119 (2): 364–367.

https://doi.org/10.1182/blood-2011-09-382408

Published: 2012

Includes: Supplemental data

Journal Articles

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Joshua Field, MD, MS, Gene Lin, MD, PhD, Maureen Okam, MD, MPH, Elaine Majerus, MD, PhD, Onyinye Onyekwere, MD, MS, Ainsley Ross, BA, Donna Neuberg, ScD, Federico Campigotto, MS, David G. Nathan, MD, Joel Linden, PhD

Blood (2011) 118 (21): 849.

https://doi.org/10.1182/blood.V118.21.849.849

Published: 2011

Journal Articles

Guilt by association

David G. Nathan

Blood (2011) 118 (14): 3758–3759.

https://doi.org/10.1182/blood-2011-08-370338

Published: 2011

Journal Articles

Pulmonary hypertension and nitric oxide depletion in sickle cell disease

H. Franklin Bunn, David G. Nathan, George J. Dover, Robert P. Hebbel, Orah S. Platt, Wendell F. Rosse, Russell E. Ware

Blood (2010) 116 (5): 687–692.

https://doi.org/10.1182/blood-2010-02-268193

Published: 2010

Journal Articles

Sickle cell disease and stroke

Luis A. Verduzco, David G. Nathan

Blood (2009) 114 (25): 5117–5125.

https://doi.org/10.1182/blood-2009-05-220921

Published: 2009

Journal Articles

Oral iron chelation: new drug, old rules

David G. Nathan

Blood (2008) 111 (2): 483–484.

https://doi.org/10.1182/blood-2007-11-123349

Published: 2008

Journal Articles

Ribosomal Protein S24 Gene Is Mutated in Diamond-Blackfan Anemia.

Blood (2006) 108 (11): 181.

https://doi.org/10.1182/blood.V108.11.181.181

Published: 2006

Journal Articles

Monosomy 7 and the myeloid malignancies

David G. Nathan

Blood (2003) 102 (6): 1938.

https://doi.org/10.1182/blood-2003-07-2360

Published: 2003

Journal Articles

Deferiprone and hepatic fibrosis

Gary M. Brittenham, David G. Nathan, Nancy F. Olivieri, John B. Porter, Martin Pippard, Elliott P. Vichinsky, David J. Weatherall

Blood (2003) 101 (12): 5089–5091.

https://doi.org/10.1182/blood-2002-10-3173

Published: 2003

Journal Articles

A novel diagnostic screen for defects in the Fanconi anemia pathway

Akiko Shimamura, Rocio Montes de Oca, John L. Svenson, Nicholas Haining, Lisa A. Moreau, David G. Nathan, Alan D. D'Andrea

Blood (2002) 100 (13): 4649–4654.

https://doi.org/10.1182/blood-2002-05-1399

Published: 2002

NARROW

Confounding in ex vivo models of Diamond-Blackfan anemia

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Human Sickle Cell Disease Increases Numbers and Activation Of Peripheral Blood Myeloid Dendritic Cells, Monocytes, and Neutrophils

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients

Hemoglobin disorders: a look to the future

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Cynomolgus Monkey Invariant NKT (iNKT) Cells Recover Following Depletion by Treatment with the Anti-Invariant T Cell Receptor Antibody NKTT120

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Guilt by association

Pulmonary hypertension and nitric oxide depletion in sickle cell disease

Sickle cell disease and stroke

Oral iron chelation: new drug, old rules

Ribosomal Protein S24 Gene Is Mutated in Diamond-Blackfan Anemia.

Monosomy 7 and the myeloid malignancies

Deferiprone and hepatic fibrosis

A novel diagnostic screen for defects in the Fanconi anemia pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only